Pay in 4 interest-free payments of $7.42 Learn more
Ships within 48 hours · Estimated delivery Oct 1 - Oct 6
This dual GIP/GLP-1 receptor agonist slows gastric emptying to control blood sugar and promote satiety, which can trigger nausea, vomiting, and gastrointestinal discomfort
H.RehmanM.FahadS.TungS
The GIP component adds: Enhanced Insulin Response: Even stronger blood sugar control than GLP-1 alone Better insulin secretion timing Improved insulin sensitivity in tissues Fat Metabolism Effects: GIP receptors exist in fat tissue May influence how body stores and uses fat Potentially increases fat burning Synergistic Appetite Suppression: GIP and GLP-1 together produce greater appetite reduction More potent satiety signals Stronger overall effect This explains why tirzepatide produces 5-7% more weight loss than semaglutidethe dual action is more powerful than GLP-1 alone
Dont wait to get help
US$ 29.57
US$ 20.54
US$ 24.72
US$ 28.56
